tirzepatide or semaglutide for pcos Rising use of GLP-1 medications among women with Semaglutide vs Tirzepatide, which is
Description
While GLP-1 and GIP mainly help regulate appetite, insulin, and fullness, glucagon may help increase energy expenditure and fat metabolism
Most people reach their weight loss plateau between months 9-14, with timing varying by starting BMI
hsCRP is a general marker of systemic inflammation
Current head-to-head evidence suggests tirzepatide may produce greater average weight loss than semaglutide
Most people begin losing weight within 4 weeks of starting Tirzepatide injections
The SURMOUNT-MMO trial is examining whether tirzepatide reduces overall morbidity and mortality in adults with obesity but without diabetes
